Pharmacokinetic interactions between lamotrigine and other antiepileptic drugs in children with intractable epilepsy

Epilepsia

Volumn 37, Issue 8, 1996, Pages 769-773

  Eriksson, Ann Sofie ^a   Hoppu, Kalle ^b   Nergårdh, Arne ^b   Boreus, Lars ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

Antiepileptic drugs; Lamotrigine; Pharmacokinetic interactions; Therapeutic drug monitoring

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; ETHOSUXIMIDE; LAMOTRIGINE; PHENOBARBITAL; VALPROIC ACID; VIGABATRIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; GENERALIZED EPILEPSY; HUMAN; INTRACTABLE EPILEPSY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0029816665     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1996.tb00650.x     Document Type: Article

References (14)

1. Cheung H, Kamp D, Harris E. An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels. Epilepsy Res 1992;13:107-12.
2. Leach MJ, Marden CM, Miller AA. Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action. Epilepsia 1986;27:490-7.
3. Posner J, Holdich T, Crome P. Comparison of lamotrigine pharmacokinetics in young and elderly healthy volunteers. J Pharm Med 1991;1:121-8.
4. Cohen AF, Land GS, Breimer DD, Yuen WC, Winston C, Peck AW. Lamotrigine, a new anticonvulsant: pharmacokinetics in normal humans. Cin Pharmacol Ther 1987;42: 535-41.
5. Jawad S, Yuen WC, Peck AW, Hamilton MJ, Oxley JR, Richens A. Lamotrigine: single-dose pharmacokinetics and initial 1-week experience in refractory epilepsy. Epilepsy Res 1987;1:194-201.
6. Binnie CD, van Emde Boas W, Kasteleijn-Nolst-Trenité DGA, et al. Acute effects of lamotrigine (BW430C) in persons with epilepsy. Epilepsia 1986;27:248-54.
7. Ramsey RE, Pellock JM, Garnett WR, et al. Pharmacokinetics and safety of lamotrigine (lamictal) in patients with epilepsy. Epilepsy Res 1991;10:191-200.
8. Yuen AWC, Land G, Weatherley BC, Peck AW. Sodium valproate acutely inhibits lamotrigine metabolism. Br J Clin Pharmacol 1992;33:511-3.
9. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for classification of epilepsies and epileptic syndromes. Epilepsia 1985; 26:268-78.
10. Forssblad E, Eriksson A-S, Beck O. Liquid chromatographic determination of plasma lamotrigine in pediatric samples. J Pharm Biomed Analysis 1995;00:00-00.
11. Yau MK, Wargin WA. Single-dose and steady-state pharmacokinetic study of lamictal in healthy male volunteers. Wellcome Internal Report no. THRS/90/0024.
12. Wallace SJ. Add-on open trial of lamotrigine in resistant child seizures. Brain Dev 1990;12:734.
13. Rey E, Vauzelle F, Pons G, et al. Pharmacokinetics of lamotrigine in young epileptic children. Presented at the 5th World Confernece on Clinical Pharmacology and Therapeutics, Yokohama, Japan, 1992:154.
14. Yuen WC, Peck AW. Lamotrigine pharmacokinetics: oral and i.v. infusion in man. Br J Clin Pharmacol 1988;26:00-00.